Piet L. C. M. van Riel
Piet L. C. M. van Riel publishes mostly in Rheumatology, Immunology and Hematology, on topics such as Rheumatoid Arthritis Research and Therapies, Systemic Lupus Erythematosus Research and Spondyloarthritis Studies and Treatments.
- World rank
- #123,067 of 7,710,434 ranked researchers
- Rank in Netherlands
- #2,980 of 107,149
- Works
- 518
- Citations
- 48k
- Citations per work
- 92.7
What does Piet L. C. M. van Riel research?
Piet L. C. M. van Riel's work is mostly in Medicine (55%), Immunology and Microbiology (8%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences28354.6%
- Medicine28354.6%
- Everything else19637.8%
- Life Sciences397.6%
- 1Rheumatology41% of their works
- 2Immunology8% of their works
- 3Hematology5% of their works
- 4Pathology and Forensic Medicine3% of their works
- 5Radiology, Nuclear Medicine and Imaging3% of their works
- 6Oncology3% of their works
Research topics
- Rheumatoid Arthritis Research and Therapies
- Systemic Lupus Erythematosus Research
- Spondyloarthritis Studies and Treatments
- Autoimmune and Inflammatory Disorders Research
- Monoclonal and Polyclonal Antibodies Research
- Gout, Hyperuricemia, Uric Acid
- Biosimilars and Bioanalytical Methods
- Chronic Lymphocytic Leukemia Research
Which keywords describe Piet L. C. M. van Riel's research?
The keywords of their largest research topics: Autoantibodies, Cardiovascular Risk, Inflammation, Biological Therapy, Rheumatoid Arthritis, Ankylosing Spondylitis, Antiphospholipid Syndrome and Spondyloarthritis.
- Genomic Aberrations
- Immunogenicity
- Uric Acid
- Therapeutic Antibodies
- Juvenile Idiopathic Arthritis
- Monoclonal Antibodies
- Spondyloarthritis
- Ankylosing Spondylitis
- Biological Therapy
- Cardiovascular Risk
- Autoantibodies
- Inflammation
- Rheumatoid Arthritis
- Antiphospholipid Syndrome
- Systemic Lupus Erythematosus
- Hemophagocytic Lymphohistiocytosis
- Fc Receptors
- Hyperuricemia
- Biosimilars
- Chronic Lymphocytic Leukemia
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 20 words, with their numbers
- Autoantibodies4442 topics
- Cardiovascular Risk3872 topics
- Inflammation3872 topics
- Biological Therapy3531 topic
- Rheumatoid Arthritis3531 topic
- Ankylosing Spondylitis911 topic
- Antiphospholipid Syndrome911 topic
- Spondyloarthritis911 topic
- Systemic Lupus Erythematosus911 topic
- Monoclonal Antibodies632 topics
- Hemophagocytic Lymphohistiocytosis591 topic
- Juvenile Idiopathic Arthritis591 topic
- Fc Receptors361 topic
- Therapeutic Antibodies361 topic
- Hyperuricemia341 topic
- Uric Acid341 topic
- Biosimilars271 topic
- Immunogenicity271 topic
- Chronic Lymphocytic Leukemia221 topic
- Genomic Aberrations221 topic
Where does Piet L. C. M. van Riel work?
Piet L. C. M. van Riel's main affiliation in the publication record is Radboud University Nijmegen, Netherlands.
How many publications and citations does Piet L. C. M. van Riel have?
OpenAlex counts 518 works and 48,014 citations for Piet L. C. M. van Riel, an h-index of 92, ranking #123,067 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Piet L. C. M. van Riel. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.